Alembic Pharmaceuticals

Alembic Pharmaceuticals

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts

Fostering a Quality Culture in the Pharmaceutical Industry

Advancements in Computer-Aided Drug Design for Pharmaceutical Research

Why India is Gaining Popularity for Clinical Trials

Usage of Conversational AI in the Health Insurance Sector

The Future of Kidney Transplants in India

Strategies for India to Reduce Its API Dependence on China

Business Impact of USFDA Approvals on Indian Pharma Companies

Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions

Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives

Why Adapting Flexibility in IP Rights will Drive Generics Market

Meeting the Challenges of High-Potency API (HPAPI) Production

Strategies for Optimizing Pharmaceutical Supply Chain Efficiency

The Future of Pharma: Embracing Continuous Manufacturing

AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality

The Future of Medicine: Harnessing the Power of RNA-based Therapeutics

The Role of Orphan Drugs in Treating Rare Diseases

Emerging Technologies Shaping the Future of Drug Formulation

Impact of Human Factors Engineering on Medical Device Safety

Top 10 Retail Pharmacies In India - 2024 | Pharma Outlook

Editor's Guest

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts
Jaideep Gogtay, Global Chief Medical Officer, Cipla

Fostering a Quality Culture in the Pharmaceutical Industry
Dr. S. Eswara Reddy, Joint Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO)

Changing Landscape for LTBI and Syndromic Testing Methodologies
Manoj Jagathmohan, Director & Head, India & South Asia, QIAGEN